The global generative AI in healthcare market, valued at $1.84 billion in 2024, is projected to grow at a 31.4% CAGR to reach $21.64 billion by 2034. Growth is fueled by solutions for medical imaging, diagnostics, drug discovery, and administrative automation, addressing physician burnout and improving clinical outcomes. North America leads the market due to advanced infrastructure and investments, while cloud-based deployments and large language models dominate technology use. Challenges include regulatory hurdles, data privacy, and integration with legacy systems, but opportunities exist in specialized AI models and emerging markets.
Piper Sandler reaffirmed its 'Overweight' rating on Microsoft and set a $540 price target, implying about 40% upside from current levels. The firm highlighted Microsoft's new AI-driven cybersecurity products and strong Azure growth as key drivers. De...
MEXC's RealStocks platform, launched in June 2026, saw SpaceX (SPCX) capture nearly 30% of trading volume and user activity, marking it as the most popular stock among over 7,000 US stocks and ETFs available. AI-related stocks collectively accounted ...
Anthropic CEO Dario Amodei clarified that his company does not support banning open-weight AI models, countering industry rumors. He emphasized that open-weight models without dangerous capabilities are beneficial public goods that aid businesses and...
Microsoft introduced MAI-Cyber-1-Flash, its first AI model for detecting cybersecurity vulnerabilities, which outperforms competitors like Anthropic and Google when paired with OpenAI's GPT-5.4. This model will be integrated into Project Perception, ...
Anthropic CEO Dario Amodei clarified that his company does not support banning open-weight AI models, which users can download and modify. This statement follows a coalition of tech firms urging policymakers to avoid premature restrictions on such mo...
